Scleromyxedema and dermato-neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib

American Journal of Hematology

Volumn 86, Issue 10, 2011, Pages 893-896

  Fett, Nicole M ^a,b   Toporcer, Mary B ^c   Dalmau, Josep ^b   Shinohara, Michi M ^b   Vogl, Dan T ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Doylestown Dermatology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BORTEZOMIB; DEXAMETHASONE; LENALIDOMIDE; PROTEIN;

ADULT; ANTIBIOTIC THERAPY; BRAIN DISEASE; CASE REPORT; CONFUSION; DERMATO NEURO SYNDROME; DYSARTHRIA; DYSPHAGIA; ELECTROENCEPHALOGRAPHY; ELECTROPHORESIS; ENDOTRACHEAL INTUBATION; FATIGUE; HUMAN; LETHARGY; LETTER; LUMBAR PUNCTURE; MALE; MENTAL CONCENTRATION; MULTIPLE MYELOMA; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCLEROMYXEDEMA; SKIN DISEASE; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREMOR; URINALYSIS; WEAKNESS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BORONIC ACIDS; DEXAMETHASONE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PYRAZINES; SCLEROMYXEDEMA;

EID: 80052884407     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22131     Document Type: Letter

References (19)

1. Berger JR, Dobbs MR, Terhune MH, Maragos WF. The neurologic complications of scleromyxedema. Medicine (Baltimore) 2001; 80: 313-319.
2. Farmer ER, Hambrick GWJr, Shulman LE. Papular mucinosis. A clinicopathologic study of four patients. Arch Dermatol 1982; 118: 9-13.
3. Gholam P, Hartmann M, Enk A. Arndt-Gottron scleromyxoedema: Successful therapy with intravenous immunoglobulins. Br J Dermatol 2007; 157: 1058-1060.
4. Godby A, Bergstresser PR, Chaker B, Pandya AG. Fatal scleromyxedema: Report of a case and review of the literature. J Am Acad Dermatol 1998; 38: 289-294.
5. Gonzalez J, Palangio M, Schwartz J, et al. Scleromyxedema with dermato-neuro syndrome. J Am Acad Dermatol 2000; 42: 927-928.
6. Kantor GR, Bergfeld WF, Katzin WE, et al. Scleromyxedema associated with scleroderma renal disease and acute psychosis. J Am Acad Dermatol 1986; 14: 879-888.
7. Lai a Fat RF, Suurmond D, Radl J, van Furth R. Scleromyxoedema (lichen myxoedematosus) associated with a paraprotein, IgG 1 of type kappa. Br J Dermatol 1973; 88: 107-116.
8. Milam CP, Cohen LE, Fenske NA, Ling NS. Scleromyxedema: Therapeutic response to isotretinoin in three patients. J Am Acad Dermatol 1988; 19: 469-477.
9. Rey JB, Luria RB. Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. J Am Acad Dermatol 2009; 60: 1037-1041.
10. River Y, Levy I, Gilead L, et al. Fever, convulsions and coma in scleromyxedema: A "dermato-neuro syndrome". Neurology 1996; 46: 1778-1779.
11. Verier A, Jouet JP, Muller JP, et al. Recurrent coma, papular mucinosis and benign dysglobulinemia. Rev Neurol (Paris) 1987; 143: 791-797.
12. Webster GF, Matsuoka LY, Burchmore D. The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis). J Am Acad Dermatol 1993; 28: 105-108.
13. Sansbury JC, Cocuroccia B, Jorizzo JL, et al. Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol. 2004; 51: 126-131.
14. Cokonis Georgakis CD, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol 2006; 24: 493-497.
15. Jacob SE, Fien S, Kerdel FA. Scleromyxedema, a positive effect with thalidomide. Dermatology 2006; 213: 150-152.
16. Rongioletti F, Rebora A. Cutaneous mucinoses: Microscopic criteria for diagnosis. Am J Dermatopathol 2001; 23: 257-267.
17. Rongioletti F, Rebora A. Updated classification of papular mucinosis, lichen myxedematosus, and scleromyxedema. J Am Acad Dermatol 2001; 44: 273-281.
18. Illa I, de la Torre C, Rojas-Garcia R, et al. Steady remission of scleromyxedema 3 years after autologous stem cell transplantation: An in vivo and in vitro study. Blood 2006; 108: 773-774.
19. Sroa N, Campbell S, Bechtel M. Intravenous immunoglobulin therapy for scleromyxedema: A case report and review of literature. J Drugs Dermatol 2010;9: 263-265.